Top COO Executive Search Firm in Hyderabad for Pharma & Biotech — 2026

Pharmaceuticals and biotech are Hyderabad's signature industry, and the COO sits at the operational core of Genome Valley, the bulk-drugs and API corridor, the vaccine and CDMO base and the city's dense formulations manufacturing. This officer is the operations and regulatory-execution leader: owner of USFDA and WHO-GMP manufacturing, quality systems, supply continuity, yield and the audit-ready discipline on which the entire business depends. The role is profoundly operational and distinct from the CEO's strategy seat and the CTO's R&D-and-process-innovation seat — it is about running compliant, inspection-tested operations at scale, where one data-integrity lapse or one failed inspection can close a site. Hyderabad's defining scarcity is the operator who has carried major regulatory inspections and remediation while still driving cost, throughput and capacity.

Compensation reflects the regulated, capital-intensive nature of pharma — a strong base with performance and retention components — and benefits from Hyderabad's lower cost base than Bengaluru, widening the field of genuinely inspection-hardened operators. The stakeholder map spans the CEO and board, quality and regulatory affairs, plant and site leadership, and the global innovator clients for whom CDMOs manufacture. References are taken from those who have stood with the candidate through USFDA inspections, warning-letter remediation and tech transfers, because the question that decides a pharma COO mandate — can this leader keep regulated manufacturing running and compliant as it scales — is answered only by people who have been through an inspection beside them.